Dr. Woodruff was featured in a recent article in Evidence-Based Oncology. Read the article below:
Fertility Preservation in Young Cancer Patients
Published Online: November 17, 2014
Surabhi Dangi-Garimella, PhD
Advanced diagnostic tools and innovative treatment measures in cancer have increased cancer survival rates in the United States. Efforts by the various stakeholders in the drug development process—research scientists, the pharmaceutical industry, the FDA—resulted in the approval of 6 new anticancer agents over a 1-year period ending July 31, 2014, according to the 2014 Progress Report by the American Association for Cancer Research. Additionally, 5 previously approved agents were endorsed for alternate indications.1Along with increased incidence, there has been a significant increase in the number of cancer survivors. While the United States had an estimated 3 million survivors in 1971, that estimate is expected to reach about 14.5 million in 2014, with nearly 380,000 having been diagnosed as children or adolescents.1 One issue that plagues cancer survivors is quality of life, which could stem from either emotional or physical problems, or a combination of the two. Infertility is a major concern: irradiation of the testes or a regimen that includes chemotherapy, especially alkylating agents, can reduce fertility.
To read the rest of the article, please click here.